Thursday, October 31, 2013

Reuters: Regulatory News: NY's Barclays Center box holders claim shabby treatment due to race

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
50% off Print Subscription of USA Today

Get the news delivered to your doorstep. Lock in the savings and receive USA Today for just $0.75 a day.
From our sponsors
NY's Barclays Center box holders claim shabby treatment due to race
Nov 1st 2013, 00:12

By Ellen Wulfhorst

NEW YORK | Thu Oct 31, 2013 8:12pm EDT

NEW YORK Oct 31 (Reuters) - A group of Barclays Center luxury box holders sued the giant events center in Brooklyn on Thursday, claiming they have been treated badly because they are black.

The federal lawsuit filed by Ludwig's Drug Store, which seeks $4 million in damages, claims its manager and two other staffers who bought into the box have been "harassed, followed and questioned."

The three men say they are the only black box holders at Barclays, which opened in September 2012 and can hold as many as 19,000 people. It has 101 luxury suites, according to its website.

The Brooklyn-based drug store signed a three-year lease for nearly $1 million for a luxury box three weeks ago, according to the lawsuit.

Since then, the three say in the lawsuit they have been treated with suspicion, ignored by staff, forced to wait long times for orders that sometimes never arrive and once were billed $1,000 for a pizza that arrived late and was cold. Their luxury box is rarely cleaned, they say.

The complaint is the latest in a string of accusations of racism at commercial spots in New York.

Several black customers complained in recent days that they were stopped by police after making luxury purchases at Barneys New York and at Macy's Inc, and Barneys and the police were named in a lawsuit filed by a student who said he was detained after buying an expensive belt.

The complaints against the stores have prompted an investigation by the state attorney general into their security practices.

The treatment by Barclays is "unlawful discriminatory practice because of race," said the lawsuit filed in U.S. District Court in Brooklyn.

Barclays spokesman Barry Baum said in a statement that it would "immediately and thoroughly" investigate the claims.

"We have a zero tolerance policy for any type of discriminatory behavior. It is against everything that Barclays Center stands for," Baum said, noting that Barclays had not received legal papers nor complaints from the box holders.

The attorney representing the three men declined to speak to the media, his office said.

In the year since it has opened, Barclays has hosted shows by such top performers as Jay Z, Barbra Streisand, the Rolling Stones and Paul McCartney. It is home to the Brooklyn Nets and will be home to the New York Islanders professional hockey team starting in 2015.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: U.S. Senate panel passes plan to restrict, not end, surveillance

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
Free Bestselling eBooks

Free national bestsellers for your eReader - Fiction, Nonfiction & more! Join 1.5 million book lovers now. Sign-up in under 10 seconds to get the free daily email.
From our sponsors
U.S. Senate panel passes plan to restrict, not end, surveillance
Oct 31st 2013, 22:57

By Patricia Zengerle

WASHINGTON | Thu Oct 31, 2013 6:57pm EDT

WASHINGTON Oct 31 (Reuters) - The U.S. Senate Intelligence Committee approved legislation on Thursday to tighten controls on the government's sweeping electronic eavesdropping programs, but allows them to continue.

In a classified hearing, the panel voted 11-4 for a measure that puts new limits on what intelligence agencies can do with bulk communications records and imposes a five-year limit on how long they can be retained.

Despite growing national concern about surveillance, the "FISA Improvements Act" would not eliminate the program, which became public earlier this year when former National Security Agency contractor Edward Snowden leaked information that the government collects far more internet and telephone data than previously known.

"The NSA call-records program is legal and subject to extensive congressional and judicial oversight, and I believe it contributes to our national security. But more can and should be done to increase transparency and build public support for privacy protections in place," Senator Dianne Feinstein, chairwoman of the Intelligence Committee, said in a statement.

The act also requires the special court that oversees the collection programs to designate outside officials to provide independent perspective and assist in reviewing matters that present novel or significant interpretations of the law.

It also requires Senate confirmation of the National Security Agency director and inspector general.

It was not clear whether the Intelligence Committee's bill would become law. It must pass the full Senate, as well as the House of Representatives before it could be sent to President Barack Obama for his signature.

It also faces formidable opposition.

Democratic Senator Patrick Leahy and Republican Representative James Sensenbrenner this week introduced a bill to end what they termed the government's "dragnet collection" of information.

Sensenbrenner and Leahy, the chairman of the Senate Judiciary Committee, which also oversees the Foreign Intelligence Surveillance Act, were the primary authors of the USA Patriot Act implemented after the Sept. 11, 2001, attacks to improve the government's ability to protect its citizens.

Democratic Senator Ron Wyden, one of the four committee members who voted against the intelligence committee's legislation, said the measure codifies surveillance practices that he thinks are too broad.

"More and more Americans are saying that they refuse to give up their constitutionally guaranteed liberties for the appearance of security; the intelligence committee has passed a bill that ignores this message," Wyden said in a statement.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: UPDATE 3-AstraZeneca names Dunoyer CFO as drug sales, profits drop

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
The Best Way to Manage your Money.

Start using Mint today to set a budget, track your goals and do more with your money.
From our sponsors
UPDATE 3-AstraZeneca names Dunoyer CFO as drug sales, profits drop
Oct 31st 2013, 11:02

Thu Oct 31, 2013 7:02am EDT

* Marc Dunoyer appointed to replace Simon Lowth as CFO

* Q3 sales $6.25 billion vs consensus $6.44 billion

* Q3 core EPS $1.21 vs consensus $1.22

* 2013 spending to increase at upper end of guided range

* Shares down 2 percent

By Ben Hirschler

LONDON, Oct 31 (Reuters) - AstraZeneca promoted Marc Dunoyer to be its new chief financial officer on Thursday, plugging a gap in the British drugmaker's top management team as it grapples with falling sales and profits.

Dunoyer, 61, who joined from rival GlaxoSmithKline in June and currently heads portfolio and product strategy, will replace well-respected finance chief Simon Lowth, whose departure to join BG Group had been announced.

Hit by generic competition to key drugs, sales and profits at AstraZeneca continued to slide in the third quarter, underscoring the challenge facing Chief Executive Pascal Soriot, who has been in the job for just over a year.

Lowth has been viewed as a steady hand on AstraZeneca's finances and the appointment of Dunoyer, who lacks recent direct CFO responsibility, may concern some investors.

"AstraZeneca's heavy income-focused investor base will likely be concerned over the news of Mr. Dunoyer's appointment," Citi analyst Andrew Baum said in a note.

"While a very talented and experienced industry executive, in our view, investors could fear increased risk to near-term EPS (earnings per share) and AstraZeneca's flat dividend commitment through either increased internal investment or a greater propensity to M&A."

Dunoyer, who is a French national like Soriot and takes over on Nov. 1, is a qualified accountant, but his most recent roles at GSK were as head of rare diseases and Japan.

Soriot told reporters Dunoyer offered a blend of strategic thinking and financial expertise, adding his appointment did not signal any change in dividend policy or acquisition strategy, which has so far focused on smaller deals.

Panmure Gordon analyst Savvas Neophytou said the company, at its current stage, probably needed a CFO who was "more strategic than technocratic".

Soriot and Dunoyer have their work cut out to turn around AstraZeneca after years of failure to come up with new drugs to replace those reaching the end of their patent life.

Improving AstraZeneca's record in drug research is Soriot's top priority, but he told Reuters in June that turning around the company would take three to four years.

SPENDING MORE

It will also require investment in the science behind new medicines and AstraZeneca said it expected to spend more, with 2013 spending increasing at the upper end of its prior guidance range of a low-to-mid single digit percentage rise on 2012.

Mark Clark of Deutsche Bank said higher operating costs suggested there would be "minor" downgrades in earnings forecasts.

The shares fell 2 percent by 1045 GMT following news of Dunoyer's appointment and the latest weak results.

Sales in the quarter slid by 6 percent to $6.25 billion, weighed down by the loss of patent protection on several drugs - including, in some markets, its top-selling cholesterol fighter Crestor - while EPS tumbled 28 percent.

"Core" operating profit of $2.03 billion, which excludes certain items, generated EPS of $1.21. Analysts had, on average, forecast core EPS of $1.22 and sales of $6.44 billion, according to Thomson Reuters.

The group reiterated its expectation for a mid-to-high single digit percentage fall in revenue this year, with earnings expected to decline significantly more, due to rising research and marketing costs.

Near-term hopes are pinned on new heart drug Brilinta, although its progress to date has been slow, with sales in the quarter edging up to $75 million from $65 million in the three months to end-June.

A U.S. inquiry launched this month into a clinical trial involving the drug also raises uncertainties.

Growth in drug sales in China, where destocking and an anti-corruption drive disrupted business, slowed to 13 percent from 21 percent in the second quarter. But AstraZeneca fared a lot better than GlaxoSmithKline, the company at the centre of the scandal, whose China sales crashed 61 percent in the third quarter.

Overall revenue in emerging markets was up 5 percent and AstraZeneca said it expected a high single digit revenue increase in emerging markets for the full year.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: Bank regulators propose tougher trading book rules

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
The Best Way to Manage your Money.

Start using Mint today to set a budget, track your goals and do more with your money.
From our sponsors
Bank regulators propose tougher trading book rules
Oct 31st 2013, 10:52

LONDON | Thu Oct 31, 2013 6:52am EDT

LONDON Oct 31 (Reuters) - Banks using bespoke models for determining how much capital they hold to cover trading book risks should also use a standardised approach as a backstop, global regulators said on Thursday.

The Basel Committee of banking supervisors from nearly 30 countries published a second round of consultation on reforming how risks on trading books could be added up after finding wide discrepancies among banks.

Hawkish policymakers in Britain and the United States have said that Basel's current system of using in-house models to assign weightings to risky assets to determine capital levels is too complicated and easily gamed.

"This is achieved by establishing a closer calibration of the two approaches, requiring mandatory calculation of the standardised approach by all banks, and requiring mandatory public disclosure of standardised capital charges by all banks, on a desk-by-desk basis," the committee said in a statement.

The committee is also considering the merits of introducing the standardised approach as a floor or surcharge to the models-based approach.

"However, it will only make a final decision on this issue following a comprehensive quantitative impact study, after assessing the impact and interactions of the revised standardised and models-based approaches," the committee said.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: RPT-Ethanol, oil groups blitz White House as biofuel rule nears

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
The Best Way to Manage your Money.

Start using Mint today to set a budget, track your goals and do more with your money.
From our sponsors
RPT-Ethanol, oil groups blitz White House as biofuel rule nears
Oct 31st 2013, 11:00

Thu Oct 31, 2013 7:00am EDT

By Cezary Podkul

NEW YORK Oct 30 (Reuters) - Biofuel and oil industry lobbyists have raced to the White House over the past two weeks in a last-ditch effort to sway controversial ethanol blending rules for next year, fueling talk of that a decision may be just a few weeks away.

The White House has hosted at least 17 meetings related to the rules since October 21, after the federal government reopened for business following a shutdown. Some 84 industry executives and lobbyists have visited, with about 70 percent of the attendees representing biofuel interests, a Reuters review of meeting records shows.

Participants in the meetings say Obama administration officials who are vetting the proposed renewable fuel rules have given no indication of which way they are leaning. But privately, some observers privy to the proceedings say the White House will likely support a leaked Environmental Protection Agency (EPA) proposal that would dramatically lower ethanol blending volumes

Both sides of the fiercely contested issue are hoping the agency will heed their warnings before making a final decision. The White House Office of Management and Budget (OMB) must vet the proposed rules and confer with other agencies before returning them to the EPA, so they could yet be changed during that process. The EPA must then release the draft rules publicly before finalizing them.

Although that date is likely months away, the leak of the EPA's draft proposal has complicated the matter, in effect giving an early, unexpected start for public comments.

The EPA document proposed backtracking on the so-called Renewable Fuel Standard, or RFS, by cutting the 2014 quota of corn-based ethanol fuel used in gasoline to 13 billion gallons, versus the 14.4 billion called for in the 2007 RFS law. The move set off a storm of criticism from biofuel backers.

"We said . . . 'it would be a capitulation to the oil industry' if the corn ethanol figure is lowered," said Roger Johnson, president of the National Farmers Union, who discussed the rules with the White House OMB last Friday.

Johnson said OMB officials gave nothing away. "They didn't say anything. They didn't even confirm that stuff that is being reported even is being considered," he said.

Yet some Washington insiders say the EPA's proposal seems likely to stand. In setting quotas for 2013, the agency had already hinted that refiners and blenders were reaching a limit in how much ethanol they can mix into the gasoline pool.

"It's pretty clear the stars are aligning for the EPA to make a major revision in how it implements the RFS," said Bob McNally, White House energy adviser to former President George W. Bush, who championed the 2007 law.

A spokesman for the OMB declined to comment. A spokeswoman for the EPA did not return a request for comment.

FARMERS VS. DRIVERS

The debate over mixing home-grown biofuels into the U.S. fuel supply has raged for years. But it is reaching a fever pitch this year as oil refiners say they can not inject more than the traditional 10 percent ethanol into gasoline without risking damage to most car engines on the road today.

After ethanol credits used to meet ethanol blending quotas spiked in price earlier this year due to fears of a shortage, the oil industry stepped up its argument that injecting more biofuels will drive up gasoline prices.

The politically potent message has resonated in Washington. In its leaked draft proposal, the EPA called refiners' 10 percent blending limitation an "important reality."

"I think they realized that there's a problem," said Charles Drevna, president of the American Fuel and Petrochemical Manufacturers, which represents oil refiners.

To drive the point home, refinery operators Philadelphia Energy Solutions, CVR Refining and PBF Energy, who collectively refine about 1 million barrels-per-day (bpd) of oil, met with the OMB last Tuesday, a meeting record shows.

They were joined by Delta Airlines, which owns a 185,000 bpd refinery in Pennsylvania that can not blend any biofuels with its fuel output. That puts the airline on the hook to buy credits to make up its blending shortfall -- at a cost of $66 million for the past two quarters, filings show.

Since the EPA proposal leak, ethanol blending credits deepened a months-long slide, falling to their lowest since late January after peaking at nearly $1.45 this July. They traded at 25 cents each on Wednesday.

'GUTTING' THE LAW

On the other side, biofuel groups that have billions at stake in the outcome of the rules say the EPA has no right to change the 2007 law, which has turned ethanol into a cottage industry across much of the U.S. corn-producing states, boosting incomes and creating jobs in rural areas.

Jeff Lautt, chief executive of South Dakota-based POET, one of the world's largest ethanol producers, warns that EPA's leaked proposal could push corn prices down by $1 a bushel or more.

"You would be sitting on the heels of a potential farm crisis," Lautt said. "It would be gutting the pure, core intention of the RFS."

POET made its point to the OMB in a meeting last Thursday. Other pro-biofuel groups, including the Advanced Ethanol Council, Renewable Fuels Association, Growth Energy and the Biotechnology Industry Organization also made their case to the OMB last week, according to records of the meetings.

At least three more meetings by biofuel backers took place this week, records show, and OMB will continue to schedule meetings in response to requests while it is still reviewing the EPA's rule. Anyone can request a meeting by submitting a simple request via the OMB website.

Judging by the flood of interest, the administration is likely to be equally busy once the rule is finalized.

"I guarantee you if there's this many people going there, this is going to end up in court," said one participant who declined to be named so he could speak freely about the meeting.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: Extended Stay America IPO could value company at up to $4.2 bln

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
The Best Way to Manage your Money.

Start using Mint today to set a budget, track your goals and do more with your money.
From our sponsors
Extended Stay America IPO could value company at up to $4.2 bln
Oct 31st 2013, 11:22

Thu Oct 31, 2013 7:22am EDT

Oct 31 (Reuters) - Hotel chain Extended Stay America Inc said it expects to sell 28.3 million common shares at $18-$21 each in an initial public offering, valuing the company at as much as $4.2 billion.

The offering would raise about $594 million at the higher end of the projected price range. ()

The company, headed by former Starbucks Corp Chief Executive James Donald, was bought for $3.9 billion at a bankruptcy auction in October 2010 by a group including hedge funds Paulson & Co and Centerbridge Partners and private equity firm Blackstone Group LP.

Blackstone and Paulson each hold about 27.8 percent of the Charlotte, North Carolina-based company, which operates of 682 hotels in the United States and Canada.

Blackstone has also filed IPO plans for U.S. hotel operator Hilton Worldwide Inc. Sources have told Reuters it is seeking a valuation of about $30 billion.

Deutsche Bank, Goldman Sachs and J.P. Morgan are lead underwriters for the offering.

The hotel industry's revenue per available room, a measure of room rates and occupancy levels, has increased by about 6.9 percent in the Americas over the past three years, according to Smith Travel Research.

Private equity firms have been trying to sell or list assets to take advantage of a surging IPO market as a market rally and low interest rates entice investors into stocks.

Total proceeds raised from IPOs rose to $11.80 billion in the third quarter from $6.70 billion a year earlier.

Shares of Brixmor Property Group Inc, a shopping center company owned by Blackstone Group, rose as much as 4 percent in their market debut on Wednesday.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

Reuters: Regulatory News: UPDATE 1-Liffe launches coffee, cocoa warehousing review

Reuters: Regulatory News
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com 
50% off Print Subscription of USA Today

Get the news delivered to your doorstep. Lock in the savings and receive USA Today for just $0.75 a day.
From our sponsors
UPDATE 1-Liffe launches coffee, cocoa warehousing review
Oct 31st 2013, 11:29

Thu Oct 31, 2013 7:29am EDT

By Sarah McFarlane

LONDON Oct 31 (Reuters) - Exchange NYSE Liffe has launched a consultation into warehousing practices in the coffee and cocoa markets, it said in a notice published on its website.

Warehouse storage rents and load-out rates have sparked debate since business models used controversially in metals markets were replicated in coffee and cocoa.

The warehouses make money partly by charging low rates to attract material and higher rates to those taking delivery to retrieve material, while at the same time limiting access.

In metals, warehousing complaints have resulted in U.S.-based lawsuits by consumers, distributors and others alleging aluminium price-fixing and anti-competitive behaviour by investment banks, large trading houses and the LME.

Coffee traders said warehousing delays and expenses have contributed to certified stocks of robusta coffee sliding to historical lows, fuelling expectations of significant price rises to attract fresh beans. Exchange certified coffee backs the futures contract.

The exchange is asking market participants to give information on rents, movement out rates and the amount of notice given to warehouses on upcoming stock movements.

"The information provided as part of this review will assist the exchange in assessing whether the terms and conditions under which Liffe exchange-related goods are handled and stored are appropriate when compared with those for commercial goods," the notice said.

Responses to the consultation paper were due by Nov.13 and the exchange did not specify a timeline for when it would update market participants.

The consultation comes ahead of InterContinentalExchange's (ICE) acquisition of NYSE Liffe soft commodity contracts, with completion of the deal delayed from Nov. 4 to a later date, yet to be announced, to allow additional time for regulatory approvals.

Last week ICE said that once it has acquired NYSE Liffe soft commodity contracts, warehousing practices in coffee and cocoa were amongst the top items to be tackled.

  • Link this
  • Share this
  • Digg this
  • Email
  • Reprints

You are receiving this email because you subscribed to this feed at blogtrottr.com.

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions
Read more »

 
Great HTML Templates from easytemplates.com.